Latest Breaking News On - குறிப்பு பட்டியலிடப்பட்டுள்ளது மருந்து - Page 1 : comparemela.com

Nifty may open down, but strength seen at lower levels - The Hindu BusinessLine

Nifty may open down, but strength seen at lower levels April 23, 2021 Privi Speciality, Glnnd Pharma, Tata Motors scrips likely to see action today Rising Covid cases are likely keep Indian markets in a bear grip on Friday even as global markets present mixed cues. The US markets slumped almost one per cent overnight on fears of imposition of new capital gains tax by Joe Biden administration. SGX Nifty at 14,331 indicates a gap-down opening of 70 points for Nifty futures, which closed at 14,403 on Thursday. The SGX Nifty futures recovered from the day s low of 14,260, signalling some value buying happening at lower levels.

United statesUnited kingdomCastle bromwichUttar pradeshPidilite industrieMohit nigamMahesh babaniJoe bidenVinod nairHead of research at geojit financial servicesFairfax india holdings corporationPg electroplast ltdDrug administrationTata motorsPrivi speciality chemicalsClinigen healthcare

Gland Pharma receives approval for generic Foscarnet Sodium Injection

Gland Pharma received approval from the United States Food and Drug Administration (US FDA) for generic Foscarnet Sodium Injection, 6000 mg/250 mL (24 mg/mL) Single-Dose Bag for Infusion. Generic Foscarnet Sodium Injection is the bioequivalent and therapeutically equivalent to the Reference Listed Drug (RLD), Foscavir Injection, 24 mg/mL, of Clinigen Healthcare. With this approval, Gland Pharma secured the first generic offering status in Single-Dose Bag for Infusion. Gland Pharma is backward integrated with in-house API source for this product. Gland Pharma intends to supply this product globally and recently launched the product in the Canadian market. Global markets size is estimated to be $50 million.

United statesDrug administrationGland pharmaUnited states foodFoscarnet sodium injectionSingle dose bagReference listed drugFoscavir injectionCompetitive generic therapySodium injectionCapital marketஒன்றுபட்டது மாநிலங்களில்சுரப்பி பார்மாஒன்றுபட்டது மாநிலங்களில் உணவுகுறிப்பு பட்டியலிடப்பட்டுள்ளது மருந்துபோட்டி ஜெநெரிக் சிகிச்சை

Gland Pharma received approval for generic Foscarnet Sodium Injection, Single-Dose Bag for Infusion

Gland Pharma received approval for generic Foscarnet Sodium Injection, Single-Dose Bag for Infusion
equitybulls.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from equitybulls.com Daily Mail and Mail on Sunday newspapers.

United statesClinigen healthcareDrug administrationGland pharma limitedFoscarnet sodium injectionSingle dose bagTime zonePharma limitedUnited states foodGeneric foscarnet sodium injectionReference listed drugGland pharmaCompetitive generic therapySodium injectionஒன்றுபட்டது மாநிலங்களில்சுரப்பி பார்மா வரையறுக்கப்பட்டவை

Strides receives USFDA approval for Potassium Chloride for Oral Solution

Strides receives USFDA approval for Potassium Chloride for Oral Solution
equitybulls.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from equitybulls.com Daily Mail and Mail on Sunday newspapers.

United statesPharma research software solutionStrides pharma incStrides pharma science ltdStrides pharma science limitedUnited states food drug administrationPotassium chlorideTime zonePharma science limitedStrides pharma globalOral solutionUnited states foodDrug administrationReference listed drugStrides pharmaஒன்றுபட்டது மாநிலங்களில்

Strides gets USFDA nod for potassium chloride for oral solution

Strides gets USFDA nod for potassium chloride for oral solution March 15, 2021 × Strides Pharma Science Limited (Strides) has announced that its step-down wholly-owned subsidiary, Strides Pharma Global Pte Limited, Singapore, has received approval for Potassium Chloride for Oral Solution USP, 20 mEq from the United States Food & Drug Administration (USFDA). The product is bio-equivalent and therapeutically equivalent to the Reference Listed Drug (RLD), Potassium Chloride for Oral Solution USP, 20 mEq, of Pharma Research Software Solution, LLC. Potassium chloride oral solution is indicated for the treatment and prophylaxis of hypokalemia with or without metabolic alkalosis, in patients for whom dietary management with potassium-rich foods or diuretic dose reduction are insufficient.

Pharma research software solutionStrides pharma incStrides pharma science limitedStrides pharma global pteUnited states food drug administrationStrides pharma global pte limitedPotassium chlorideOral solutionUnited states foodDrug administrationReference listed drugபார்மா ஆராய்ச்சி மென்பொருள் தீர்வுமுன்னேற்றங்கள் பார்மா இன்க்முன்னேற்றங்கள் பார்மா அறிவியல் வரையறுக்கப்பட்டவைமுன்னேற்றங்கள் பார்மா உலகளாவிய ட்முன்னேற்றங்கள் பார்மா உலகளாவிய ட் வரையறுக்கப்பட்டவை